Medical Equipment

Automated Nucleic Acid Extraction Devices Market Industry Forecast Reflecting Growth To $11.04 Billion By 2030

May 11, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Does The Forecasted Market Size Of The Automated Nucleic Acid Extraction Devices Market Compare Between 2026 And 2030?

The market for automated nucleic acid extraction devices has experienced swift growth in recent years. This market is expected to expand from $6.6 billion in 2025 to $7.32 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.9%. The increase observed in previous periods is linked to the wider adoption of molecular diagnostic testing, a rise in the incidence of infectious diseases, greater implementation of laboratory automation, an increase in clinical testing volumes, and innovations in nucleic acid chemistry.

The automated nucleic acid extraction devices market is anticipated to experience substantial growth over the coming years. Projections indicate it will expand to $11.05 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.9%. This projected expansion during the forecast period is primarily driven by factors such as an escalating demand for swift diagnostic solutions, increasing financial commitments to genomic research, the broadening scope of personalized medicine testing, greater acceptance of point-of-care molecular diagnostics, and advancements in extraction efficiency technologies. Furthermore, key developments expected within this period include a rising uptake of fully automated extraction platforms, a heightened requirement for high-throughput molecular diagnostics, the expanding implementation of integrated sample-to-result systems, a wider application of automated lab workflows, and an intensified focus on processing free from contamination.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9421&type=smp

What Core Drivers Are Transforming The Automated Nucleic Acid Extraction Devices Market?

The growing occurrence of infectious diseases is anticipated to accelerate the expansion of the automated nucleic acid extraction devices market in the future. Such diseases are conditions triggered by disease-causing microorganisms like bacteria, viruses, fungi, or parasites, which can spread directly or indirectly between individuals or from animals to people. This rise in infectious diseases, especially during worldwide health emergencies like pandemics, increases the demand for diagnostic testing. Automated nucleic acid extraction devices are crucial in preparing samples for molecular diagnostics, helping to identify viruses and bacteria. For example, as reported by GOV.UK, a UK public sector information site, in September 2023, the first half of 2023 saw a 7% increase in tuberculosis (TB) cases in England compared to the corresponding period in 2022, with reported cases climbing from 2,251 to 2,408. Consequently, the heightened occurrence of infectious diseases is propelling the expansion of the automated nucleic acid extraction devices market.

How Is The Automated Nucleic Acid Extraction Devices Market Structured Across Different Market Segments?

The automated nucleic acid extraction devices market covered in this report is segmented –

1) By Type: Instruments, Kits, Consumables

2) By Automation Level: Fully Automated, Semi-Automated

3) By End User: Hospitals, Diagnostic Centers, Forensic Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes

Subsegments:

1) By Instruments: Automated Extractors, Liquid Handling Systems

2) By Kits: DNA Extraction Kits, RNA Extraction Kits, Viral Nucleic Acid Extraction Kits

3) By Consumables: Reagents, Columns, Tips And Tubes

What Trends Are Influencing The Automated Nucleic Acid Extraction Devices Market?

Leading companies in the automated nucleic acid extraction devices market are developing innovative offerings, such as automated nucleic acid extraction workstations, to expand their customer base, increase sales, and boost revenue. An automated nucleic acid extraction workstation is defined as a specialized and automated system designed for isolating nucleic acids, including DNA and RNA, from biological samples. For example, in April 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based provider of in-vitro diagnostic products, launched the SAW-48 and the Cell Nucleic Acid Extraction Kit (Magnetic Bead Method). The SAW-48 distinguishes itself as a unique in-vitro diagnostic medical device by integrating sample loading, nucleic acid purification, and PCR setup functions into a single instrument. This innovative device is capable of concurrently processing up to 48 samples, significantly reducing the time required to obtain test results. The SAW-48 streamlines the entire process of sample loading, nucleic acid purification, and PCR setup, thereby enhancing the efficiency of STD and HPV detection. Together, the SAW-48 and the Cell Nucleic Acid Extraction Kit provide a comprehensive solution, ensuring a more efficient and streamlined approach to identifying sexually transmitted diseases and human papillomavirus.

Which Organizations Are Operating Within The Automated Nucleic Acid Extraction Devices Market?

Major companies operating in the automated nucleic acid extraction devices market are QIAGEN N.V., PerkinElmer Inc., F. Hoffmann-La Roche AG, Analytik Jena GmbH, Thermo Fisher Scientific Inc., Accubiomed Co. Ltd., AutoGen Inc., Bioneer Corporation, Tecan Group Ltd., Merck KGaA, Becton Dickinson and Company, DiaSorin Molecular LLC, BioTeke Corporation (Wuxi) Co. Ltd., Xi’an TianLong Science and Technology Co. Ltd., Jiangsu Bioperfectus Technologies Co. Ltd., Hangzhou Bloer Technology Co. Ltd., MGI Tech Co. Ltd., Aurora Biomed Inc., Promega Corporation, Hamilton Company, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Zymo Research Corporation, Agilent Technologies Inc., Danaher Corporation, Eppendorf AG, GE Healthcare Life Sciences, GenScript Biotech Corporation, Greiner Bio-One International GmbH, IntegenX Inc., MicroGEM International Company, Norgen Biotek Corp.

Access The Complete Automated Nucleic Acid Extraction Devices Market Report:

https://www.thebusinessresearchcompany.com/report/automated-nucleic-acid-extraction-devices-global-market-report

Which Region Is The Primary Market For The Automated Nucleic Acid Extraction Devices Market?

North America was the largest region in the automated nucleic acid extraction devices market in 2025. The regions covered in the automated nucleic acid extraction devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Automated Nucleic Acid Extraction Devices Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=9421&type=smp

Browse Through More Reports Similar to the Global Automated Nucleic Acid Extraction Devices Market 2026, By The Business Research Company

Nucleic Acid Extraction Instruments And Reagents Market Report 2026

https://www.thebusinessresearchcompany.com/report/nucleic-acid-extraction-instruments-and-reagents-global-market-report

Nucleic Acid Labeling Market Report 2026

https://www.thebusinessresearchcompany.com/report/nucleic-acid-labeling-global-market-report

Dna Or Rna Sample Extraction And Isolation Market Report 2026

https://www.thebusinessresearchcompany.com/report/dna-or-rna-sample-extraction-and-isolation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795